The focus of the Sloan translational research lab is on the immunologic personalization of radiotherapy also known as immune-guided radiotherapy (IM-GRT). By using pre-clinical modeling to address the important research questions identified in tumor histology, and utilizing this modeling approach as a means to identify adjuvant therapies, we aim to develop a personalized approach to radiotherapy and improve the immunologic outcome of radiotherapy.
Our mission is to develop an innovative program focused on immunologic personalization of radiotherapy, improving clinical outcomes.
Dr. Lindsey Sloan is an Assistant Professor in the Department of Radiation Oncology, University of Minnesota Medical School. She is also a Masonic Scholar at the Masonic Cancer Center, University of Minnesota. Dr. Sloan is the lead investigator in the research group.